(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.97% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Dentsply Sirona's revenue in 2025 is $3,671,000,000.On average, 18 Wall Street analysts forecast XRAY's revenue for 2025 to be $743,276,866,086, with the lowest XRAY revenue forecast at $707,369,771,106, and the highest XRAY revenue forecast at $771,204,606,626. On average, 18 Wall Street analysts forecast XRAY's revenue for 2026 to be $754,447,962,302, with the lowest XRAY revenue forecast at $669,068,869,794, and the highest XRAY revenue forecast at $798,533,895,583.
In 2027, XRAY is forecast to generate $778,984,477,205 in revenue, with the lowest revenue forecast at $723,727,447,708 and the highest revenue forecast at $821,075,571,876.